VolitionRx Limited Proceeds from Grantors
VolitionRx Limited (VNRX) reported Proceeds from Grantors of $32.65 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromGrantors · last filed 2019-08-12
- VolitionRx Limited proceeds from grantors for the quarter ending 2016-12-31 was $335.43K.
- VolitionRx Limited proceeds from grantors for the quarter ending 2016-09-30 was $0.00.
- VolitionRx Limited proceeds from grantors for the quarter ending 2015-12-31 was $0.00.
- VolitionRx Limited proceeds from grantors for the quarter ending 2015-09-30 was $0.00.
- VolitionRx Limited proceeds from grantors for fiscal 2016 was $361.32K, a 146.11% increase from fiscal 2015.
- VolitionRx Limited proceeds from grantors for fiscal 2015 was $146.81K.
| Period end | Proceeds from Grantors 3 month | Proceeds from Grantors 6 month | Proceeds from Grantors 9 month | Proceeds from Grantors 12 month |
|---|---|---|---|---|
| 2019-06-30 | $32.65K 10-Q · filed 2019-08-12 | |||
| 2016-12-31 | $335.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $335.43K derived: sum of 2 quarters · filed 2017-03-10 | $361.32K 10-K · filed 2017-03-10 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $25.89K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $25.89K 10-Q · filed 2017-08-10 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-10 | $146.81K 10-K · filed 2017-03-10 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $146.81K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $146.81K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |